For example, studies have demonstrated that tumor-infiltrating DCs exhibit decreased expression of co-stimulatory molecules such as CD86 and CD80 [9], while concurrently displaying heightened expression of immune inhibitory molecules such as programmed cell death 1 ligand 1 (PD-L1) [10]. This evidence concerns the gene CD86 and neoplasm.